| Literature DB >> 34337357 |
Yoshiyuki Noguchi1, Fumi Kano2, Nobuhiko Maiya3, Chisako Iwamoto3, Shoko Yamasaki4, Yosuke Otsubo4, Daiki Nakatsu2, Rina Kunishige1,2, Masayuki Murata1,2.
Abstract
To infer a "live" protein network in single cells, we developed a novel Protein Localization and Modification-based Covariation Network (PLOM-CON) analysis method using a large set of quantitative data on the abundance (quantity), post-translational modification state (quality), and localization/morphological information of target proteins from microscope immunostained images. The generated network exhibited synchronized time-dependent behaviors of the target proteins to visualize how a live protein network develops or changes in cells under specific experimental conditions. As a proof of concept for PLOM-CON analysis, we applied this method to elucidate the role of actin scaffolds, in which actin fibers and signaling molecules accumulate and form membrane-associated protein condensates, in insulin signaling in rat hepatoma cells. We found that the actin scaffold in cells may function as a platform for glycogenesis and protein synthesis upon insulin stimulation.Entities:
Keywords: Bioinformatics; Molecular network; Systems biology
Year: 2021 PMID: 34337357 PMCID: PMC8324808 DOI: 10.1016/j.isci.2021.102724
Source DB: PubMed Journal: iScience ISSN: 2589-0042
Figure 1Transient formation of actin domain structures upon insulin treatment in H4IIEC3 cells
(A) After transfection of the LifeAct-EGFP plasmid and serum starvation, live-cell time-lapse imaging of H4IIEC3 upon insulin treatment was performed. Images were acquired every 3 min after 1 μM insulin stimulation. Arrows indicate the actin structures. In the lower column, the period when the structures were observed in each cell are shown as arrows. Bar = 5 μm. (B) Serum-starved H4IIEC3 cells were stimulated with 1 μM insulin for 15 min, fixed, permeabilized, and stained with antibodies against Akt, phosphorylated Akt at T308 (Akt pT308), phosphorylated Akt at S473 (Akt pS473), phosphorylated GSK3β at S9 (GSK3β pS9), mTOR, phosphorylated mTOR at S2448 (mTOR pS2448), phosphorylated Erk at T202 and Y204 (Erk pT202Y204), EEA1, APPL1, phosphorylated insulin receptor at Y999 (IR pY999), or phosphorylated insulin receptor at Y1185 (IR pY1185) (green) and rhodamine-conjugated phalloidin (Actin, orange). Bar = 5 μm.
Figure 2The scheme of Protein Localization and Modification-based Covariation Network (PLOM-CON) analysis
Immunostained cell samples were prepared in 96-well plates. Each sample was fixed at a different time in the horizontal axis direction and stained by different antibodies in the vertical axis direction. Then, fluorescent images of the cells were acquired using a confocal, laser-scanning microscope equipped with autofocus equipment. Each element in the matrix corresponds to a state observed cell on the left top well (and ). We defined as the quantified value of the -th feature of the -th protein of the -th compartment in the -th cell in the matrix using NIS-Elements ver 4.4 (Nikon). For example, a feature value obtained from imaging includes nuclear brightness, nuclear volume, cytoplasmic brightness, and so on. We computed the medians of each column, then had the variables with the indices of features, compartments, and proteins. We obtained the large matrix by merging each small matrix, after removing the variables with fewer signals. The large matrix included the whole information of the features, compartments, and proteins for each time. The graphical lasso was applied to the matrix, and then the sparse precision matrix was derived. Here, if an element of the matrix is zero, the corresponding variables are conditionally independent. After computing the partial correlation matrix from the precision matrix, we took the maximum value of each block matrix (e.g., P1C1) corresponding to the unit of a compartment in a protein. To obtain a network consisting of proteins, we only focused on the elements that represented the relationships between different proteins. The matrix was then visualized as a graph that we called the ‘covariation network’. We then performed the graph clustering by using the OCG method to extract the clusters.
Figure 3Covariation networks for insulin-stimulated H4IIEC3 cells
(A) A heatmap displaying the median for feature quantities in H4IIEC3 cells at different time points after insulin treatment. Red or blue indicate that the value was increased or decreased compared to 0 min, respectively. A, B, C, D, or E in the column of item represents synthesis mean intensity, mean intensity, sum volume, sum count, or count, respectively. (B and C) Covariation networks for insulin-stimulated H4IIEC3 cells at the ρ of 0.91. Proteins stained with antibodies are represented as nodes and the edge between the pair of nodes indicates that the feature quantities of the two proteins are correlated. The location at which the feature quantity was measured is indicated by the colored region (B) or the subnode at each end of the edge (C) (red: cytosol, orange: actin scaffold, blue: nucleus). (D) The network of pAkt (Ser473) with its neighbor nodes. (E) The nodes for Akt (pSer473), p70S6K, Akt, FoxO1, MEK1 (pSer298), GSK3β (pSer9), and EEA1 with the subnodes are magnified from the covariation network of Figure 3C.
Figure 4Graph clustering of the covariation network for insulin-stimulated H4IIEC3 cells
(A) Clusters were detected using OCG algorithm from the covariation network. The mean degree, i.e. mean number of edges that the node has to other nodes, in each cluster were plotted (blue). The red line indicates the mean degree in the covariation network at each ρ. (B) Graph clustering of the covariation network for insulin-stimulated H4IIEC3 cells (ρ of 0.79). (C) A cluster with mean degree larger than that of the covariation network at the ρ of 0.79. The subnode at each end of the edge indicates where the feature quantity was measured (red: cytosol, orange: actin scaffold, blue: nucleus). (D) Graph clustering of the covariation network for insulin-stimulated H4IIEC3 cells (ρ of 0.93). (E) A cluster with mean degree larger than that of the covariation network at the ρ of 0.93. The subnode at each end of the edge indicates where the feature quantity was measured (red: cytosol, orange: actin scaffold, blue: nucleus).
Figure 5Biological evaluation of the covariation network for insulin-stimulated H4IIEC3 cells
(A) Glycogen assay in DMSO- (blue) or CK666- (red) treated cells. Six independent experiments were performed. ∗P < 0.05. (B) DMSO- or CK666-pre-treated H4IIEC3 cells were incubated with insulin for the indicated time. Western blotting was performed using antibodies against GSK3β (pSer9) and GSK3β. The mean and the standard deviation of the ratio of GSK3β (pSer9) to GSK3β are shown in the graph. Three independent experiments were performed. (C) The expanded covariation network containing the first neighbor interacting proteins. In the cluster that included both GSK3β (pSer9) and GYS2 (cluster), the proteins that interact GYS2 and function in glycogen pathway were extracted (node). (D) H4IIEC3 cells were stimulated with insulin for 15 min, and was subjected to immunofluorescence. GYG2, Myc-tagged PP1R3C, PPP1R3B, PPP1CA, and Myc-tagged STBD1 were co-stained with rhodamine-phalloidin (Actin). Bar = 10 μm. (E) Real-time PCR analysis of G6PC in DMSO- or CK666-treated cells. Three independent experiments were performed. ∗P < 0.05. ∗∗P < 0.01.
Figure 6PLOM-CON analysis for insulin-stimulated H4IIEC3 cells in the presence of CK666
H4IIEC3 cells were pretreated with 50 μM CK666 or with DMSO (control) for 20 min and then further treated with 1 μM insulin at 37°C for 1, 5, 10, 15, 20, 30, 40, 50, and 60 min. The cells were fixed and subjected to PLOM-CON analysis. (A) A heatmap displaying the median for each feature quantity for CK666-treated H4IIEC3 cells. Red or blue indicates that the value was increased or decreased compared to that at 0 min, respectively. A, B, C, D, or E in the column of item represents synthesis mean intensity, mean intensity, sum volume, sum count, or count, respectively. (B) Serum-starved H4IIEC3 cells were pretreated with 50 μM CK666 for 15 min and stimulated with insulin, and was applied to PLOM-CON analysis. A covariation network at the ρ of 0.86 is shown. The location at which the feature quantity was measured is indicated by the subnode at each end of the edge (red: cytosol, blue: nucleus). (C) The network of Akt (pSer473) with its neighbor nodes from the CK666 covariation network in B. (D) Clusters were detected using OGC algorithm from the covariation network for CK666-treated cells. The mean degrees in each cluster were plotted (blue). The red line indicates the mean degree in the covariation network for CK666-treated cells at each ρ. (E) A cluster with mean degree larger than that of the covariation network for CK666-treated cells at the ρ of 0.88. The subnode at each end of the edge indicates the location at which the feature quantity was measured (red: cytosol, orange: actin scaffold, blue: nucleus).
Figure 7Graph clustering and the biological evaluation of covariation network of insulin-stimulated, CK666-treated H4IIEC3 cells
(A-E) Serum-starved H4IIEC3 cells were pre-treated with DMSO (blue) or 50 μM CK666 (red) for 20 min, further with 1 μM insulin for 0, 5, 15, 30, 60 min, and electrophoresed protein extracts subjected to western blotting using antibodies against Akt or Akt(pSer473) (A, left), mTOR or mTOR(pSer2448) (B, left), p70S6K or p70S6K (pSer235/236) (C), 4E-BP or 4E-BP (pThr37/46) (D), and S6RP or S6RP (pSer235 and pSer236) (E, left). The mean and the standard error of the ratio of phosphorylated protein to total protein are shown in the graph (A, B, and E, right). Three independent experiments were performed. ∗P < 0.05. (F) Proposed model for the function of the actin domain in the insulin-signaling pathway.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Akt (clone C67E7) | Cell Signaling Technology | Cat#4692S; RRID: |
| Akt(pSer473) (clone D9E) | Cell Signaling Technology | Cat#4060P; RRID: |
| Akt(pThr308) (clone C31E5E) | Cell Signaling Technology | Cat#2965S; RRID: |
| APPL1 (clone D83H4) | Cell Signaling Technology | Cat#3858; RRID: |
| Arp2 (clone FMS96) | abcam | Cat#ab49674; RRID: |
| Arp3 (clone FMS338) | abcam | Cat#ab49671; RRID: |
| Bmi1 (clone EPR3745(2)) | abcam | Cat#ab126783; RRID: |
| DNMT1 (clone D63A6) | Cell Signaling Technology | Cat#5032S; RRID: |
| EEA1 (clone 14) | BD | Cat#610346; RRID: |
| eIF4E (clone Y448) | abcam | Cat#ab33766; RRID: |
| eIF4E(pSer209) (clone EP2151Y) | abcam | Cat#ab76256; RRID: |
| Elk1 (clone E277) | abcam | Cat#ab32106; RRID: |
| Erk (clone 137F5) | Cell Signaling Technology | Cat#4695S; RRID: |
| Erk(pThr202_pTyr204) (clone D13.14.4E) | Cell Signaling Technology | Cat#4370A; RRID: |
| FoxO1 (clone C29H4) | Cell Signaling Technology | Cat#2880; RRID: |
| FoxO1(acAsp19) (clone D-19) | Santa Cruz | Cat#sc-49437; RRID: |
| FoxO1(pSer256) | SAB | Cat#11115; RRID: |
| FoxO1(pSer319) | SAB | Cat#11136; RRID: |
| FoxO1(pThr24) | Cell Signaling Technology | Cat#9464; RRID: |
| GAPDH | abcam | Cat#ab83957; RRID: |
| GSK3β (clone 3D10) | abcam | Cat#ab93926; RRID: |
| GSK3β (pSer9) | abcam | Cat#ab131097; RRID: |
| GYG2 | abcam | Cat#ab204784; RRID: |
| GYS2 | abcam | Cat#ab83550; RRID: |
| HistoneH2A (clone D603A) | Cell Signaling Technology | Cat#12349; RRID: |
| IR (clone EPR5510(2)) | abcam | Cat#ab131238; RRID: |
| IR(pTyr1185) (clone E351(2)Y) | abcam | Cat#ab62321; RRID: |
| IR(pTyr999) | abcam | Cat#ab105180; RRID: |
| IRS1 (clone EP263Y) | abcam | Cat#ab40777; RRID: |
| IRS1(pSer312) | abcam | Cat#ab138456 |
| IRS1(pTyr612) | abcam | Cat#ab66153; RRID: |
| IRS2 (clone EP976Y) | abcam | Cat#ab52606; RRID: |
| IRS2(pSer731) | abcam | Cat#ab3690; RRID: |
| MEK1 (clone E342) | abcam | Cat#ab32091; RRID: |
| MEK1(pSer218_pSer222) (clone E237) | abcam | Cat#ab32088; RRID: |
| MEK1(pSer298) (clone EPR3338) | abcam | Cat#ab96379; RRID: |
| mTOR (clone 7C10) | Cell Signaling Technology | Cat#2983; RRID: |
| mTOR(pSer2442) (clone D9C2) | Cell Signaling Technology | Cat#5536; RRID: |
| p70S6K (clone EPR13429) | abcam | Cat#ab186753 |
| p70S6K(pSer411) | abcam | Cat#ab131459; RRID: |
| p70S6K(pSer424) | abcam | Cat#ab131436; RRID: |
| PDPK1 (clone EPR245) | abcam | Cat#ab109253; RRID: |
| PDPK1(pSer241) (clone EPR336(2)) | abcam | Cat#ab109460; RRID: |
| PDPK1(pTyr9) | abcam | Cat#ab111863; RRID: |
| PI3Kp85 (clone M253) | abcam | Cat#ab86714; RRID: |
| RAC2 | abcam | Cat#ab154711 |
| RAC3 (clone EPR6679(B)) | abcam | Cat#ab124943; RRID: |
| S6RP (clone 54D2) | Cell Signaling Technology | Cat#2317; RRID: |
| S6RP(pSer235_236) (clone D57.2.2E) | Cell Signaling Technology | Cat#4858; RRID: |
| WASH1 | abcam | Cat#ab157592 |
| βTubullin (clone AA2) | Sigma-Aldrich | Cat#T8328; RRID: |
| CK666 | Abcam | Cat#ab141231 |
| Hoechst 33342 | Dojindo | Cat#H346-07951 |
| Insulin solution | Sigma-Aldrich | Cat#I9278-5ML |
| Rhodamine-conjugated phalloidin | Thermo Fisher Scientific | Cat#R-415; RRID: |
| Glycogen Assay Kit (Fluorometric) | CELL BIOLABS | Cat#MET-5023 |
| Raw and analyzed data | This paper | N/A |
| Small toy dataset | This paper | |
| Rat: H4-II-E-C3 cell line | ATCC | Cat#CRL-1600; RRID:CVCL_0285 |
| Primer: PCK1 Forward: GTGGGTCCTGGACACTGACT | N/A | |
| Primer: PCK1 Reverse: AATGCCTGACAAGACTCCA | N/A | |
| Primer: G6PC Forward: GGCAATGCTGGACCAAACAC | N/A | |
| Primer: G6PC Reverse: AAACGCTCCATGGCTTCCAC | N/A | |
| Primer: PPIA Forward: GGCAATGCTGGACCAAACAC | N/A | |
| Primer: PPIA Reverse: AAACGCTCCATGGCTTCCAC | N/A | |
| Primer: PPP1R3C Forward: GAGGAGGACCTGCTTATGAGCTGCACCAGGATGAT | This paper | |
| Primer: PPP1R3C Reverse: TGTCTGGATCCCCGCTCATCGATAGGAGGCCAAGT | This paper | |
| Primer: STBD1 Forward: CCCACCATGGCATCAATGGGCGCCGTCTGGTCA | This paper | |
| Primer: STBD1 Reverse: GATCAGCTTCTGCTCGTGAATCCCCCACCACCCAT | This paper | |
| LifeAct-EGFP | N/A | |
| pCMV-Myc | Clontech | PT3282-5 |
| NIS-Elements ver 4.4 | Nikon | RRID: |
| linkcomm ver 1.0-14 | N/A | |